Format

Send to

Choose Destination
J Ethnopharmacol. 2019 Aug 8:112149. doi: 10.1016/j.jep.2019.112149. [Epub ahead of print]

UPLC-ESI-IT-TOF-MS metabolomic study of the therapeutic effect of Xuefu Zhuyu decoction on rats with traumatic brain injury.

Author information

1
College of Chemistry and Chemical Engineering, Central South University, Hunan, Changsha, PR China; College of Pharmacy, Shaoyang University, Hunan, Shaoyang, PR China. Electronic address: syyzcyf2013@163.com.
2
College of Chemistry and Chemical Engineering, Central South University, Hunan, Changsha, PR China. Electronic address: qianwu@csu.edu.cn.
3
College of Chemistry and Chemical Engineering, Central South University, Hunan, Changsha, PR China. Electronic address: zhangzhimin@csu.edu.cn.
4
Laboratory of Ethnopharmacology, Institute of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Hunan, Changsha, PR China. Electronic address: 52152913@qq.com.
5
College of Chemistry and Chemical Engineering, Central South University, Hunan, Changsha, PR China. Electronic address: ji.hongchao@foxmail.com.
6
College of Chemistry and Chemical Engineering, Central South University, Hunan, Changsha, PR China. Electronic address: hongmeilu@csu.edu.cn.
7
Laboratory of Ethnopharmacology, Institute of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Hunan, Changsha, PR China. Electronic address: wangyang_xy87@csu.edu.cn.

Abstract

It has been widely reported that Xuefu Zhuyu decoction (XFZYD), a traditional Chinese medicine, is effective in the treatment of traumatic brain injury (TBI). However, the mechanism of the therapeutic process is still not fully understood. Metabolomic technique can be used to explore the mechanisms underlying the treatment of TBI with XFZYD. The purpose of this work was to investigate the metabolic characteristics of blood samples from rats with and without XFZYD treatment and the dynamic changes in metabolite profiles on days 1, 3, 7, 14 and 21 after injury (within the severe phase of TBI) based on untargeted UPLC-ESI-IT-TOF-MS analysis. Pattern recognition, clustering analysis and metabolic pathway analysis were used to analyse the metabolomic data of three groups (a sham-operated group, a TBI model, and an XFZYD-treated TBI model). The results showed that XFZYD reversed the abnormalities in the levels of small-molecule metabolites (such as L-acetylcarnitine, L-tryptophan, indoleacrylic acid, γ-aminobutyric acid, hypotaurine, LysoPC(18:1)(11Z), creatine, L-phenylalanine and L-leucine) in TBI rats through six metabolic pathways (including phenylalanine, tyrosine and tryptophan biosynthesis; phenylalanine metabolism; valine, leucine and isoleucine biosynthesis; taurine and hypotaurine metabolism; tryptophan metabolism; and alanine, aspartate and glutamate metabolism) involved in the therapy process. XFZYD regulated the metabolic disorders of endogenous markers by the possible mechanisms of neuroprotection, energy metabolism, inflammatory response and oxidative stress. This study revealed the holistic and dynamic metabolic changes caused by XFZYD in rats with TBI and provided important research methods and approaches for exploring the multiple metabolites and metabolic pathways involved in the therapeutic effect of XFZYD on TBI.

KEYWORDS:

Traumatic brain injury; UPLC-ESI-IT-TOF-MS; Untargeted metabolomics; Xuefu Zhuyu decoction

PMID:
31401321
DOI:
10.1016/j.jep.2019.112149

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center